Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Korro Bio’s $91.5M series A brings in new investors, launches hunt for CEO

By  Karen Tkach Tuzman, Associate Editor
September 10, 2020 10:52 PM UTC

Korro Bio’s $91.5 million series A round opens the door to new leadership for the Atlas-built RNA editing company, which has been led by Executive Chairman Nessan Bermingham since its launch in 2018.

“With the series A now raised, Korro will be expanding the senior leadership team which includes a key focus on recruitment of a CEO to support the company long term in partnership with our experienced team of existing leaders, board and SAB,” Bermingham told BioCentury. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article